24 results
Chronic Myelomonocytic Leukemia (CMML)

 • Definition
 • DDx
 • Dx Tool and Risk Stratification
 • Treatment
• Dx Tool and Risk ... Stratification • Treatment ... Leukemia #CMML #oncology
Chronic Neutrophilic Leukemia (CNL)

 • Signaling Pathway
 • WHO Dx Critera
 • Risk Stratification
 • Treatment
Dx Critera • Risk ... Stratification • Treatment ... Leukemia #diagnosis #oncology
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
diagnosis and risk-stratification ... • Risks: infection ... only curative treatment ... Diagnosis #Management #treatment ... #hematology #oncology
Rewarming Methods in Hypothermia
 • Passive rewarming - Requires adequate patient physiologic mechanisms. Inadequate for more
Low benefit, low risk ... Gastric lavage - Risks ... Thoracic lavage - Risks ... Hypothermia #management #treatment ... #ebm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... patients at high risk ... interactions and bleeding risk ... also balance the risk ... Management #Hematology #Oncology
Treatment Schema for Standard-Risk Acute Lymphoblastic Leukemia
Induction: 
 • Vincristine, Steroid (dexamethasone), L-Asparaginase, Intrathecal (IT) methotrexate
Consolidation
Treatment Schema ... for Standard-Risk ... given throughout treatment ... Lymphoblastic #Leukemia #Treatment ... #timeline #oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the treatment ... Management #Hematology #Oncology
Chronic Lymphocytic Leukemia (CLL) - Summary
Overview: 
 • Most common leukemia in adults
 • Disorder of
transformation) Treatment ... chemotherapy for low-risk ... Indications for Treatment ... AIHA, PRCA) • Treatment ... Lymphocytic #Leukemia #oncology
Post-Transplantation Lymphoproliferative Disorders (PTLD)
Definition: Lymphoid and/or plasmacytic proliferations that occur as a result of immunosuppression in
immunocompetent population Risk ... liver>kidney), EBV ... ↑ LDH), rising EBV ... associated with EBV ... Lymphoproliferative #Disorders #oncology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Attempt if high risk ... Renal Failure Treatment ... management #hematology #oncology